Both high and low doses of transcranial direct current stimulation (tDCS) may improve cognition in p...

Yesterday the Food and Drug Administration (FDA) approved Vraylar (cariprazine) for the treatment of...

Light therapy has been shown to be an effective treatment for bipolar depression, but there have bee...

The Food and Drug Administration (FDA) has approved Latuda (lurasidone HCl) for the treatment of dep...

The American Journal of Psychiatry has once again received recognition from New England Journal of M...

Patients with bipolar depression who are not responding to pharmacotherapy may benefit from add-on t...

Lurasidone appears to be well tolerated and effective at reducing depressive symptoms in children an...

Adjunctive bright light therapy may help lower depressive symptoms in adults with bipolar disorder, ...